Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 Jul 21.

Published in final edited form as: Lancet Infect Dis. 2015 Dec 8;16(3):303–310. doi: 10.1016/S1473-3099(15)00378-3

Table 1.

Baseline demographic characteristics of study subjects

		Vaccine (N=30)	Placebo (N=10)

Sex
	Male, n (%)	15 (50.0)	5 (50.0)
	Female, n (%)	15 (50.0)	5 (50.0)
Race
	White, n (%)	30 (100)	10 (100)
	Other, n(%)	0 (0.0)	0 (0.0)
Age (years)
	Mean±SD	27.6±8.2	27.2±8.8
	Median (Q1, Q3)	25.5 (22.0, 30.0)	25.5 (21.0, 29.0)
	Min. – Max.	19.0–49.0	19.0–46.0
Weight (kg)
	Mean±SD	65.6±11.6	67.6±14.5
	Median (Q1, Q3)	62.0 (58.8, 71.0)	64.5 (57.0, 76.0)
	Min. – Max.	43.0–89.0	50.0–101.0
Height (cm)
	Mean±SD	172.7±11.2	173.1±9.2
	Median (Q1, Q3)	172.0 (164.0, 185.0)	172.0 (167.0, 178.0)
	Min. – Max.	148.0–190.0	162.0–191.0

SD=standard deviation; Q1=upper quartile; Q3=lower quartile